Mark Larché

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi Immunoregulation by targeting T cells in the treatment of allergy and asthma
    Mark Larché
    Immunology and Allergy Division, Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada
    Curr Opin Immunol 18:745-50. 2006
  2. ncbi Update on the current status of peptide immunotherapy
    Mark Larché
    Department of Medicine, Division of Clinical Immunology and Allergy, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Allergy Clin Immunol 119:906-9. 2007
  3. ncbi Regulatory T cells in allergy and asthma
    Mark Larché
    Department of Medicine, Division of Clinical Immunology and Allergy, Faculty of Health Sciences, McMaster University, 1200 Main St W, Hamilton, ON, L8N 3Z5, Canada
    Chest 132:1007-14. 2007
  4. ncbi Peptide and recombinant immunotherapy
    Mark Larché
    Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, HSC 4H20, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada
    Immunol Allergy Clin North Am 31:377-89, xi. 2011
  5. ncbi T cell epitope-based allergy vaccines
    Mark Larché
    Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, HSC 4H20, Hamilton, ON L8N 3Z5, Canada
    Curr Top Microbiol Immunol 352:107-19. 2011
  6. ncbi Immunological mechanisms of allergen-specific immunotherapy
    Mark Larché
    Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada
    Nat Rev Immunol 6:761-71. 2006
  7. ncbi Immunotherapy with peptides
    D Moldaver
    Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada
    Allergy 66:784-91. 2011

Collaborators

Detail Information

Publications7

  1. ncbi Immunoregulation by targeting T cells in the treatment of allergy and asthma
    Mark Larché
    Immunology and Allergy Division, Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada
    Curr Opin Immunol 18:745-50. 2006
    ....
  2. ncbi Update on the current status of peptide immunotherapy
    Mark Larché
    Department of Medicine, Division of Clinical Immunology and Allergy, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Allergy Clin Immunol 119:906-9. 2007
    ..Further studies are required in larger numbers of subjects and with peptides derived from a variety of allergens...
  3. ncbi Regulatory T cells in allergy and asthma
    Mark Larché
    Department of Medicine, Division of Clinical Immunology and Allergy, Faculty of Health Sciences, McMaster University, 1200 Main St W, Hamilton, ON, L8N 3Z5, Canada
    Chest 132:1007-14. 2007
    ..Further studies are required to precisely define the mechanisms of development and action of these cells, and to identify and evaluate novel targets for the treatment of allergic diseases...
  4. ncbi Peptide and recombinant immunotherapy
    Mark Larché
    Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, HSC 4H20, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada
    Immunol Allergy Clin North Am 31:377-89, xi. 2011
    ....
  5. ncbi T cell epitope-based allergy vaccines
    Mark Larché
    Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, HSC 4H20, Hamilton, ON L8N 3Z5, Canada
    Curr Top Microbiol Immunol 352:107-19. 2011
    ..Here we review clinical and mechanistic studies associated with peptide immunotherapy targeting allergy to cats or to bee venom. ..
  6. ncbi Immunological mechanisms of allergen-specific immunotherapy
    Mark Larché
    Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada
    Nat Rev Immunol 6:761-71. 2006
    ..This article reviews the development of allergen-specific immunotherapy, our current understanding of its mechanisms of action and its future prospects...
  7. ncbi Immunotherapy with peptides
    D Moldaver
    Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada
    Allergy 66:784-91. 2011
    ..Peptide immunotherapy may provide a safe and efficacious alternative to conventional subcutaneous and/or sublingual approaches using native allergen preparations...